Jacob N, Jacob CO: Genetics of rheumatoid arthritis: an impressionist perspective. Rheum Dis Clin North Am. 2012, 38: 243-257.
Article
PubMed
Google Scholar
Falgarone G, Jaen O, Boissier MC: Role for innate immunity in rheumatoid arthritis. Joint Bone Spine. 2005, 72: 17-25.
Article
PubMed
Google Scholar
Tian Z, Gershwin ME, Zhang C: Regulatory NK cells in autoimmune response. J Autoimm. 2012, 39: 206-215.
Article
CAS
Google Scholar
Namekawa T, Snyder MR, Yen J-H, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ: Killer cell activating receptors function as costimulatory molecules on CD4 + CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol. 2000, 165: 1138-1145.
Article
CAS
PubMed
Google Scholar
Parham P: MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005, 5: 201-214.
Article
CAS
PubMed
Google Scholar
Rajalingam R: Human diversity of killer cell immunoglobulin-like receptors and disease. Korean J Hematol. 2011, 46: 216-228.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cooley S, Wesdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG, Geraghty D, Spellman S, Haagenson MD, Ladner M, Trachtenberg E, Parham P, Miller JS: Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010, 116: 2411-2419.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yokoyama WM: Inhibitory receptors signal activation. Immunity. 2008, 29: 515-517.
Article
CAS
PubMed
Google Scholar
Raulet DH, Vance RE, McMahon CW: Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001, 19: 291-330.
Article
CAS
PubMed
Google Scholar
Kuśnierczyk P: Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Front Immunol. 2013, doi:10.3389/fimmu.2013.00008
Google Scholar
Cauli A, Shaw J, Giles J, Hatano H, Rysnik O, Payeli S, McHugh K, Dessole G, Porru G, Desogus E, Fiedler S, Hölper S, Carette A, Blanco-Gelaz MA, Vacca A, Piga M, Ibba V, Garau P, La Nasa G, López-Larrea C, Mathieu A, Renner C, Bowness P, Kollnberger S: The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLAB*27:09. Rheumatology. 2013, 52: 1952-1962.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kuśnierczyk P, Majorczyk E: Pas de quatre: an interaction of HLA-B*2705 and KIR3DL2 homodimers in spondyloarthropathies. Rheumatology. 2013, 52: 1931-1932.
Article
PubMed
Google Scholar
McGeough CM, Berrar D, Wright G, Mathews C, Gilmore P, Cunningham RT, Bjourson AJ: Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy. Rheumatol Int. 2012, 32: 1647-1653.
Article
CAS
PubMed
Google Scholar
Cronstein BN: Going with the flow: methotrexate, adenosine, and blood flow. Ann Rheum Dis. 2006, 65: 421-422.
Article
CAS
PubMed
PubMed Central
Google Scholar
Capone D, Spanò A, Gentile A, Ferrara G, Itto E, Palmiero G, Basile V, Oriente P: Are there differences in methotrexate kinetics between responding and nonresponding patients with rheumatoid arthritis?. BioDrugs. 2000, 13: 373-379.
Article
CAS
PubMed
Google Scholar
Marchesoni A, Battafarano N, Arreghini M, Panni B, Gallazzi M, Tosi S: Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone. Rheumatology (Oxford). 2003, 42: 1545-1549.
Article
CAS
Google Scholar
Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, Kremer J: Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum. 2004, 50: 2766-2774.
Article
CAS
PubMed
Google Scholar
Maillefert JF, Puéchal X, Falgarone G, Lizard G, Ornetti P, Solau E, Legré V, Lioté F, Sibilia J, Morel J, Maynadié M, Réseau Rhumato Study Group: Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis. Joint Bone Spine. 2010, 77: 558-563.
Article
CAS
PubMed
Google Scholar
Aslibekyan S, Brown EE, Reynolds RJ, Redden DT, Morgan S, Baggott JE, Sha J, Moreland LW, O'Dell JR, Curtis JR, Mikuls TR, Bridges SL, Arnett DK: Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial. Pharmacogenomics J. 2014, 14: 48-53.
Article
CAS
PubMed
Google Scholar
Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W: Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Pharmacogenomics J. 2013, 13: 227-234.
Article
CAS
PubMed
Google Scholar
Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993, 3: 729-740.
Article
Google Scholar
Fuchs HA, Brooks RH, Callahan LF, Pincus T: A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum. 1989, 32: 531-537.
Article
CAS
PubMed
Google Scholar
Majorczyk E, Pawlik A, Łuszczek W, Nowak I, Wiśniewski A, Jasek M, Kuśnierczyk P: Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun. 2007, 8: 678-683.
Article
CAS
PubMed
Google Scholar
Frohn C, Schlenke P, Ebel B, Dannenberg C, Bein G, Kitchner H: DNA typing for natural killer cell inhibiting HLA-Cw groups NK1 and NK2 by PCR-SSP. J Immunol Meth. 1998, 218: 155-160.
Article
CAS
Google Scholar
Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995, 12: 921-927.
CAS
PubMed
Google Scholar
Téo FH, de Oliveira RT, Mamoni RL, Ferreira MC, Nadruz W, Coelho OR, Fernandes Jde L, Blotta MH: Characterization of CD4 + CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis. Cell Immunol. 2013, 281: 11-19.
Article
PubMed
Google Scholar
Niccoli G, Apa R, Lanzone A, Liuzzo G, Spaziani C, Sagnella F, Cosentino N, Moro F, Martinez D, Morciano A, Bacà M, Pazzano V, Gangale MF, Tropea A, Crea F: CD4 + CD28 null T lymphocytes are expanded in young women with polycystic ovary syndrome. Fertil Steril. 2011, 95: 2651-2654.
Article
PubMed
Google Scholar
Pinto-Medel MJ, García-León JA, Oliver-Martos B, López-Gómez C, Luque G, Arnáiz-Urrutia C, Orpez T, Marín-Bañasco C, Fernández O, Leyva L: The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis. J Neuroimmunol. 2012, 243: 1-11.
Article
CAS
PubMed
Google Scholar
Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, Gawrońska-Szklarz B: The expansion of CD4 + CD28- T cells in patients with rheumatoid arthritis. Arthritis Res Ther. 2003, 5: R210-R213.
Article
CAS
PubMed
PubMed Central
Google Scholar
Smoleńska Ż, Pawłowska J, Daca A, Soroczyńska-Cybula M, Witkowski J, Bryl EM: Disease activity in patients with long-lasting rheumatoid arthritis is associated with changes in peripheral blood lymphocyte subpopulations. Pol Arch Med Wewn. 2012, 122: 591-598.
PubMed
Google Scholar
van Bergen J, Thompson A, van der Slik A, Ottenhoff THM, Gussekloo J, Koning F: Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol. 2004, 173: 6719-6726.
Article
CAS
PubMed
Google Scholar
Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ: Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001, 193: 1159-1167.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nowak I, Magott-Procelewska M, Kowal A, Miazga M, Wagner M, Niepiekło-Miniewska W, Kamińska M, Wiśniewski A, Majorczyk E, Klinger M, Łuszczek W, Pawlik A, Płoski R, Barcz E, Senitzer D, Kuśnierczyk P: Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. PLoS One. 2012, 7: e44718-
Article
CAS
PubMed
PubMed Central
Google Scholar
Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR: Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011, 39: D913-D919.
Article
CAS
PubMed
Google Scholar
Middleton D, Gonzalez A, Gilmore PM: Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum Immunol. 2007, 68: 128-134.
Article
CAS
PubMed
Google Scholar
Yen JH, Lin CH, Tsai WC, Wu CC, Ou TT, Hu CJ, Liu HW: Killer cell immunoglobulin-like receptor gene’s repertoire in rheumatoid arthritis. Scand J Rheumatol. 2006, 35: 124-127.
Article
CAS
PubMed
Google Scholar
Romão VC, Canhão H, Fonseca JE: Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?. BMC Medicine. 2013, 11: 17-
Article
PubMed
PubMed Central
Google Scholar